Back to top
more

Arkema (ARKAY)

(Delayed Data from OTC)

$66.48 USD

66.48
13,948

-0.71 (-1.06%)

Updated Aug 4, 2025 01:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Arkema to Invest $20M to Build New Rilsan Clear Unit in Singapore

by Zacks Equity Research

ARKAY to invest $20 million in Rilsan Clear unit in Singapore, which will triple its global production capacity of transparent polyamides.

Zacks Equity Research

New Strong Sell Stocks for July 7th

by Zacks Equity Research

ARKAY, AAL and COLD have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2025.

Zacks Equity Research

New Strong Sell Stocks for June 26th

by Zacks Equity Research

ARKAY, BRDCY and ANF have been added to the Zacks Rank #5 (Strong Sell) List on June 26 2025.

Zacks Equity Research

New Strong Sell Stocks for June 24th

by Zacks Equity Research

BRDCY, ARKAY and BCSF have been added to the Zacks Rank #5 (Strong Sell) List on June 24 2025.

Zacks Equity Research

Arkema Completes 400 Million Euros Undated Hybrid Bond Issuance

by Zacks Equity Research

The funds raised will primarily be used to refinance one of ARKAY's two existing hybrid bonds valued at 300 million euros.

Zacks Equity Research

Arkema to Expand its Portfolio of Low-GWP Refrigerant Solutions

by Zacks Equity Research

ARKAY is expanding its range of next-generation refrigerants by offering HFO blends under its Forane brand.

Zacks Equity Research

Strength Seen in DuPont de Nemours (DD): Can Its 12.4% Jump Turn into More Strength?

by Zacks Equity Research

DuPont de Nemours (DD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Arkema Inks New 8-Year Biomethane Supply Agreement With ENGIE

by Zacks Equity Research

This contract represents a significant advancement in ARKAY's energy transition, demonstrating its dedication to actively reducing its carbon footprint.

Zacks Equity Research

New Strong Sell Stocks for February 7th

by Zacks Equity Research

CSX, ARKAY and CBFV have been added to the Zacks Rank #5 (Strong Sell) List on February 7, 2025.

Zacks Equity Research

New Strong Sell Stocks for January 31st

by Zacks Equity Research

ARKAY, CSX and CABGY have been added to the Zacks Rank #5 (Strong Sell) List on January 31, 2024.

Zacks Equity Research

ARKAY Launches Global Mass Balance Solutions to Cut Carbon Footprint

by Zacks Equity Research

The mass balancing technique by Arkema can help to speed this shift by including renewable and recycled feedstocks into supply chains.

Zacks Equity Research

Fast-paced Momentum Stock Arkema (ARKAY) Is Still Trading at a Bargain

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Arkema (ARKAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

Are Investors Undervaluing Arkema (ARKAY) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Arkema (ARKAY) Gets ISCC+ for Powder Coating Resins Facility

by Zacks Equity Research

The facility of Arkema (ARKAY) includes a polyester resin production line and a cutting-edge R&D laboratory dedicated to increasing the sustainability and performance of powder coating materials

Zacks Equity Research

Arkema (ARKAY) Unveils New Pebax Elastomer Unit in France

by Zacks Equity Research

This new facility presents a significant opportunity for Arkema (ARKAY) to meet growing demand in existing and new applications.

Zacks Equity Research

Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation

by Zacks Equity Research

Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.

Zacks Equity Research

Is Arkema (ARKAY) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

ARKAY vs. AVNT: Which Stock Is the Better Value Option?

by Zacks Equity Research

ARKAY vs. AVNT: Which Stock Is the Better Value Option?

Zacks Equity Research

Arkema (ARKAY) to Acquire Arc Building Products in Ireland

by Zacks Equity Research

This project by Arkema (ARKAY) is scheduled to be completed in the first quarter of 2024.

Zacks Equity Research

Arkema (ARKAY) Finalizes 54% Stake Buy in PI Advanced Materials

by Zacks Equity Research

Arkema's (ARKAY) acquisition of a controlling stake in PI Advanced Materials will solidify its position in cutting-edge technologies for advanced electronics and electric mobility.

Zacks Equity Research

Arkema (ARKAY) to Expand DMDS Production Capacity in Texas

by Zacks Equity Research

Arkema (ARKAY) is investing Euro 130 million to expand its DMDS production capacity in Texas to meet the surging demand for renewable fuels.

Zacks Equity Research

Arkema (ARKAY) Expands Organic Peroxide Production in China

by Zacks Equity Research

Arkema (ARKAY) is investing Euro 50 million to boost organic peroxide production in China for renewable energy markets.

Zacks Equity Research

Arkema (ARKAY) Boosts Polymers Range With Majority Stake in PIAM

by Zacks Equity Research

Arkema (ARKAY) acquires a controlling stake in PI Advanced Materials, broadening its high-performance polymer range and transforming it into a pure specialty materials player.

Zacks Equity Research

Should Value Investors Buy Arkema (ARKAY) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

ARKAY or AKZOY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ARKAY vs. AKZOY: Which Stock Is the Better Value Option?